Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reflects strong financial performance, with record high free cash flow and a debt-free position. The SmartEquine acquisition and Chewy+ program are expected to enhance margins. Management's optimistic guidance for EBITDA margin expansion and strategic use of AI further support a positive outlook. However, some uncertainty exists due to management's reluctance to provide specific guidance on certain initiatives. Overall, the positive financials and strategic initiatives suggest a likely stock price increase in the near term.
Net Sales (Q4 2025) $3.26 billion, an 8.1% year-over-year increase. This growth reflects strong execution, continued share gains, and consistent performance across customer growth and spend per customer.
Net Sales (Full Year 2025) $12.6 billion, an 8.3% year-over-year increase. The growth was driven by stable category environment, customer growth, and increased spend per customer.
Active Customers 21.3 million, a 4% year-over-year increase. Net additions were up by more than 810,000 year-over-year, driven by improvements across all elements of the active customer equation.
Autoship Customer Sales (Q4 2025) $2.7 billion, representing 84% of total net sales, a nearly 13% year-over-year increase. This reflects the strength of the recurring revenue model.
Autoship Customer Sales (Full Year 2025) $10.5 billion, representing 83.3% of total net sales, a 14% year-over-year increase. This highlights the strength of the recurring revenue model.
NSPAC (Q4 2025) $591, a 4% year-over-year increase. Growth was driven by premium mix into high-margin categories and health and wellness verticals.
Gross Margin (Q4 2025) 29.4%, a 90 basis points year-over-year expansion. This was driven by sponsored ads growth, premium mix into high-margin categories, and a rational promotional environment.
Gross Margin (Full Year 2025) 29.8%, a 60 basis points year-over-year expansion. This was driven by similar factors as Q4, including premium mix and sponsored ads growth.
SG&A (Q4 2025) $607 million or 18.6% of net sales. Includes $10 million of one-time transaction costs related to the SmartEquine acquisition. Excluding these costs, SG&A leverage improved by 20 basis points.
SG&A (Full Year 2025) $2.4 billion or 18.8% of net sales, flat year-over-year. Excluding one-time costs, SG&A leverage remained consistent.
Advertising and Marketing Expense (Full Year 2025) $825 million or 6.5% of net sales, a 30 basis points year-over-year improvement. This reflects improved efficiency in marketing spend.
Adjusted Net Income (Q4 2025) $115 million, translating to $0.27 adjusted earnings per share. This reflects strong profitability.
Adjusted Net Income (Full Year 2025) $541 million, translating to $1.27 adjusted earnings per share. This reflects strong profitability and operational efficiency.
Adjusted EBITDA (Q4 2025) $162 million, representing a 5.0% adjusted EBITDA margin, a 120 basis points year-over-year expansion. This reflects strong operational leverage.
Adjusted EBITDA (Full Year 2025) $719 million, representing a 5.7% adjusted EBITDA margin, a 90 basis points year-over-year expansion. This reflects structural strength and operating discipline.
Free Cash Flow (Q4 2025) $232 million, a record high for the company. This highlights improved earnings quality and capital efficiency.
Free Cash Flow (Full Year 2025) $562.4 million, a record high for the company. This reflects strong cash generation and operational efficiency.
Net Cash Provided by Operating Activities (Full Year 2025) $691.6 million, reflecting strong operational performance.
Capital Expenditures (Full Year 2025) $129.2 million, reflecting disciplined capital allocation.
Cash, Cash Equivalents, and Marketable Securities (End of 2025) $879 million, with an overall liquidity position of approximately $1.7 billion. The company remains debt-free.
Chewy Vet Care Expansion: Opened 10 new practices in 2025, reaching 18 locations across 5 states. Performance exceeded expectations with strong utilization and high customer and veterinarian satisfaction.
Chewy Made Launch: Introduced a unified owned brand platform, Chewy Made, to deliver high-quality products and drive growth. Expansion includes dog and cat consumables, with a focus on accessible price points and high-demand formats.
E-commerce Growth: Secular shift towards e-commerce continues, benefiting Chewy due to its convenience, transparency, and auto-replenishment features.
AI Integration: Deployed AI across purchase experience, service operations, and supply chain. Expected to contribute low tens of millions of dollars in 2026 and approximately $50 million in annualized savings by 2027.
Houston Fulfillment Center: Ramp-up of next-generation fulfillment center to enhance operational efficiency.
Share Gains and Margin Expansion: Focused on share gains, margin expansion, and free cash flow generation. Achieved 8.3% net sales growth in 2025 and expects 8-9% growth in 2026.
SmartEquine Acquisition: Acquired SmartEquine, expected to contribute $80 million in net sales for 2026.
Pet Industry Growth: The pet industry is expected to grow at a low single-digit rate in 2026, with limited contribution from pricing and predominantly volume-driven growth. This could pose challenges for Chewy's revenue growth if market conditions do not improve.
Customer Growth: Chewy's customer growth is projected to remain in the low single digits, which may limit the company's ability to significantly expand its revenue base.
Macroeconomic Environment: Chewy's growth and profitability are not dependent on macroeconomic reacceleration, but any adverse macroeconomic conditions could still impact consumer spending and demand for pet products.
Supply Chain and Fulfillment: Chewy is relying on efficiencies from its Houston Fulfillment Center and AI-driven improvements. Any disruptions or delays in these initiatives could impact cost savings and operational efficiency.
AI Implementation: Chewy's AI-driven efficiencies are expected to contribute to cost savings, but delays or challenges in scaling these technologies could impact the projected financial benefits.
Private Brand Expansion: The launch of Chewy Made and expansion into new product categories carry risks related to customer adoption and competitive pressures from established brands.
Veterinary Care Expansion: Chewy's expansion into veterinary care with Chewy Vet Care involves operational risks, including maintaining high customer and veterinarian satisfaction and scaling the platform effectively.
Advertising and Marketing Costs: Chewy's advertising and marketing expenses are expected to remain consistent, but any inefficiencies or increased competition could lead to higher costs and reduced profitability.
Pet Industry Dynamics: Chewy expects the pet industry dynamics in 2026 to largely mirror 2025, with steady and resilient demand but without cyclical acceleration. Industry growth is projected to be in the low single digits, driven predominantly by volume rather than pricing. E-commerce penetration is expected to continue increasing, benefiting Chewy's digital platform.
Customer Growth and Net Sales Per Active Customer (NSPAC): Chewy anticipates continued quarterly sequential net additions of 150,000 to 250,000 customers. NSPAC growth is expected through premium and health mix shifts, private brand expansion, and deeper customer engagement.
Margin Expansion: Chewy expects further profitability expansion in 2026, with SG&A leverage strengthening due to the ramp-up of the Houston Fulfillment Center and AI-driven efficiencies. Adjusted EBITDA margin is projected to expand by approximately 100 basis points year-over-year, reaching 6.6% to 6.8%.
AI-Driven Efficiencies: AI-driven efficiencies are expected to contribute low tens of millions of dollars in 2026, with a significant step-up to approximately $50 million or more in annualized savings by 2027.
Private Brand Expansion: Chewy plans to launch 'Chewy Made,' a unified owned brand platform, in April 2026. This includes expanding dog and cat consumables and consolidating existing brands under this platform.
Veterinary Care Expansion: Chewy aims to scale its Chewy Vet Care (CVC) platform, which has shown strong performance and customer satisfaction. Veterinary care is viewed as a key growth vector and value creation pillar.
2026 Financial Guidance: Chewy projects net sales of $13.6 billion to $13.75 billion, representing 8% to 9% year-over-year growth. Adjusted EBITDA is expected to range from $900 million to over $930 million. Q1 2026 net sales are forecasted at $3.33 billion to $3.36 billion, with adjusted diluted EPS of $0.40 to $0.45.
Share Repurchase Program: Over the course of the year, we repurchased and retired approximately 6.8 million shares, spending approximately $257 million on share repurchases in 2025. Share repurchases will remain a key part of our capital allocation strategy and we expect our level of activity to increase relative to 2025, reflecting both the strength of our cash generation and our view of the current valuation.
The earnings call reflects strong financial performance, with record high free cash flow and a debt-free position. The SmartEquine acquisition and Chewy+ program are expected to enhance margins. Management's optimistic guidance for EBITDA margin expansion and strategic use of AI further support a positive outlook. However, some uncertainty exists due to management's reluctance to provide specific guidance on certain initiatives. Overall, the positive financials and strategic initiatives suggest a likely stock price increase in the near term.
The earnings call summary presents a mixed picture. The financial performance and shareholder return plans are average, with no major surprises. Market strategy and product development updates show potential but lack immediate impact. The Q&A section reveals some uncertainties, particularly regarding settlement payments and management's vague responses. While there are positive aspects like private label progress, the overall sentiment remains cautious, leading to a neutral rating. Without specific market cap data, the stock reaction is expected to be mild.
Chewy's earnings call highlights strong financial performance, with significant growth in adjusted net income and a solid cash position. The strategic focus on programs like Autoship and Chewy+ enhances customer retention and profitability, while marketing efficiency improvements are sustainable. Despite some concerns about Q4 margin decline, the overall guidance and strategic initiatives like CVC indicate optimism. The Q&A session reveals positive analyst sentiment, though some guidance specifics were withheld. Given these factors, the stock is likely to see a positive reaction, with potential gains in the 2% to 8% range.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.